receptors (P2X4Rs) are ligand-gated ion channels capable of conducting cations such as Na ϩ . Endogenous cardiac P2X4R can mediate ATP-activated current in adult murine cardiomyocytes. In the present study, we tested the hypothesis that cardiac P2X receptors can induce Na ϩ entry and modulate Na ϩ handling. We further determined whether P2X receptor-induced stimulation of the Na ϩ /Ca 2ϩ exchanger (NCX) has a role in modulating the cardiac contractile state. Changes in Na ϩ -K ϩ -ATPase current (Ip) and NCX current (INCX) after agonist stimulation were measured in ventricular myocytes of P2X4 transgenic mice using whole cell patch-clamp techniques. The agonist 2-methylthio-ATP (2-meSATP) increased peak I p from a basal level of 0.52 Ϯ 0.02 to 0.58 Ϯ 0.03 pA/pF. 2-meSATP also increased the Ca 2ϩ entry mode of INCX (0.55 Ϯ 0.09 pA/pF under control conditions vs. 0.82 Ϯ 0.14 pA/pF with 2-meSATP) at a membrane potential of ϩ50 mV. 2-meSATP shifted the reversal potential of I NCX from Ϫ14 Ϯ 2.3 to Ϫ25 Ϯ 4.1 mV, causing an estimated intracellular Na ϩ concentration increase of 1.28 Ϯ 0.42 mM. These experimental results were closely mimicked by mathematical simulations based on previously established models. KB-R7943 or a structurally different agent preferentially opposing the Ca 2ϩ entry mode of NCX, YM-244769, could inhibit the 2-meSATPinduced increase in cell shortening in transgenic myocytes. Thus, the Ca 2ϩ entry mode of INCX participates in P2X agonist-stimulated contractions. In ventricular myocytes from wild-type mice, the P2X agonist could increase I NCX, and KB-R7943 was able to inhibit the contractile effect of endogenous P2X4Rs, indicating a physiological role of these receptors in wild-type cells. The data demonstrate a novel Na ϩ entry pathway through ligand-gated P2X4Rs in cardiomyocytes.
purinergic receptors; Na ϩ -K ϩ -ATPase; Na ϩ /Ca 2ϩ exchanger; contraction; myocytes INTRACELLULAR Na ϩ CONCENTRATION ([Na ϩ ] i ) and its homeostasis are important in regulating the contractile and electrical activity of the heart (2). Sarcolemmal Na ϩ -K ϩ -ATPase (Na ϩ pump), with energy derived from the hydrolysis of ATP, generates an outward pump current carried by Na ϩ at rest as well as during action potentials (6) . The Na ϩ /Ca 2ϩ exchanger (NCX), through its Ca 2ϩ entry mode, can also extrude Na ϩ from the cardiac myocyte (7, 11) . Several members of both P2X receptor (P2XR) and P2Y receptor subfamilies, including P2X4 receptors (P2X4Rs), are expressed in the heart (1, 16) . Activation of cardiac P2XRs by extracellular ATP enhances the contraction of isolated myocytes and intact hearts (15, 20) . Cardiac-specific transgenic (TG) overexpression of human P2X4Rs (P2X4R TG) enhanced basal and 2-methylthio-ATP (2-meSATP)-stimulated contractions (8) . Overexpression of the P2X4R protected against calsequestrin overexpressioninduced pressure overload and postinfarct heart failure (30, 35, 36, 37) . A physiological role of endogenous cardiac myocyte P2X4Rs was recently studied (37) . Using cardiac-specific conditional knockout of P2X4Rs, the study showed that knockout mice exhibited a more severe heart failure phenotype after left coronary ligation and after aortic banding. P2XRs are ligand-gated ion channels that are permeable to Na ϩ , K ϩ , and Ca 2ϩ with a reversal potential near 0 mV (17, 22) . Extracellular ATP can induce nonselective cationic current in murine (27) , rat (25) , and guinea pig (19) cardiac ventricular myocytes. Under normal extracellular Ca 2ϩ concentration ([Ca 2ϩ ] o ; 1.8 mM), Ca 2ϩ contributes ϳ8% of the total inward current induced by ATP via homotrimeric human P2X4Rs expressed in human embryonic kidney cells (4) . However, most of the ATP-induced inward current is carried by Na ϩ (4, 27) . In the present study, we examined the effects of Na ϩ entry via P2XRs on the activities of either the Na ϩ pump or NCX as each is sensitive to intracellular Na ϩ changes. Myocyte contraction was also tested in the presence of Ca 2ϩ entry mode NCX inhibitors KB-R7943 (2-{2-[4-(4-nitrobenzyloxyl)phenyl]ethyl}isothiourea) or YM-244769 (9N-(3-aminobenzyl)-6-{4-[(3-fluorobenzyl)oxyl]phenoxy} nicotinamide) to determine the role of NCX in 2-meSATP-stimulated contraction. Experiments were carried out in P2X4R TG cardiac ventricular myocytes to facilitate detection of an effect on Na ϩ pump and NCX activities by P2X agonist. Currentvoltage (I-V) relationships of the Na ϩ pump and NCX were also simulated with mathematical modeling (14) . Similar experiments were carried out in ventricular myocytes from wildtype (WT) mice to explore the physiological relevance of this receptor in modulating Na ϩ handling.
MATERIALS AND METHODS
Isolation of adult cardiac ventricular myocytes. P2X4R TG mice were generated and bred as previously described (9, 27, 35) . Animals were maintained according to a protocol approved by the Institutional Animal Care and Use Committee of the University of Connecticut Health Center and conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Cardiac ventricular myocytes were obtained from 3-mo-old P2X4 TG or WT mice of either sex by an enzymatic dissociation procedure (27) . Briefly, we cannulated the aorta of excised hearts and perfused it at 37°C with Ca 2ϩ -free oxygenated buffer containing (in mM) 125 NaCl, 4.4 KCl, 1 MgCl2, 4 HEPES, 18 NaHCO3, 11 glucose, and 3 2,3-butanedione monoxime (pH 7.3). After 2-3 min, the coronaries were free of blood, and the perfusion buffer was switched to the same buffer containing 0.08 mg/ml Liberase Blendzyme 4 (Roche Molecular Biochemicals) and 25 M CaCl2 for 10 min. The left ventricles were minced and titurated to yield myocytes. Myocytes were then exposed ultimately to and kept at 1.0 mM external CaCl2 for experiments. At the end of the isolation procedure, myocytes that were studied needed to meet the criteria of maintaining a rod shape without blebs or blurred striation in light microscopy, remaining quiescent without spontaneous contraction, and capable of being paced for contraction shortening measurements. All myocytes were studied without any preselection bias. Experiments were carried out at room temperature (22-23°C) and were completed within 5 h after myocyte isolation.
Whole cell patch-clamp method. Electrodes were prepared from borosilicate glass pipette (1.2-mm inner diameter) with a two-step pulling procedure and filled with pipette solution (see below). Electrode resistances were 2-4 M⍀. The pipette was connected via an Ag-AgCl wire to the head stage of an amplifier (List EPC-7, Medical Systems, Greenvale, NY). After electrical contact was established for a few minutes, membrane capacitance was calculated from a Ϫ5-mV voltage step. Voltage commands and data acquisition were accomplished with Axon pCLAMP software (version 9.0).
NCX current measurement. To measure NCX current (I NCX), electrodes were filled with a solution containing (mM) 135 cesium aspartate, 5 Na 2ATP, 3 MgCl2, 10 HEPES, and 10 EGTA (pH 7.3 adjusted with CsOH). The outlet of a rapid solution changing device (SF-77B, Warner Instrument) was brought within 50 m of the cell. The superfusion medium was then changed to a modified Tyrode solution (5.4 mM KCl was omitted and 10 mM CsCl, 10 M nifedipine, and 5 M ouabain were added to Tyrode solution) to block K ϩ current, L-type Ca 2ϩ current (ICa,L), and Na ϩ pump current (Ip), respectively. The voltage protocol used to elicit INCX was as follows: from a holding potential of Ϫ80 mV, a brief 10-ms step to ϩ80 mV was followed by a 2-s repolarizing ramp to Ϫ100 mV. The ramp was applied to myocytes three times at 1-s intervals, and the superfusing fluid was then rapidly changed to a solution containing 10 mM NiCl2 for 10 s. At the end of the Ni 2ϩ application, the same ramp protocol was applied again. Three Ni 2ϩ -sensitive current traces from 60 to 100 mV were averaged to construct the I-V relationship of INCX under control conditions (5, 34). 2-meSATP (3 M) was then added to the superfusion solution for 3-4 min while the myocyte was clamped at Ϫ80 mV. The same procedures of ramp protocol and rapid solution change were applied again in the presence of 2-meSATP. The I-V relationship of INCX, taken as the Ni 2ϩ -sensitive current, was compared in the absence and presence of 2-meSATP.
To measure only the Ca 2ϩ entry mode of INCX, the current at ϩ30 mV was continuously recorded before and after rapid application of 10 mM Ni 2ϩ . During the subsequent 2-meSATP exposure, the myocyte was held at Ϫ80 mV to promote Na ϩ entry. After 3-4 min, the holding potential was changed to ϩ30 mV again, and Ni 2ϩ was applied to block the Ca 2ϩ entry mode of INCX. Ip measurement. Myocytes were voltage clamped with the same pipette solution as in INCX experiments. Pipette Na ϩ was varied from 5 to 100 mM by equimolar adjustment of Cs ϩ and Na ϩ concentrations. After electrical contact was established and membrane capacitance was obtained, the bath solution was then changed to 0 mM K ϩ -containing Tyrode solution to block Ip. The solution also contained 5 mM NiCl2 to block INCX and ICa,L (31, 33) . The holding potential was set to Ϫ80 mV to promote 2-meSATP-induced inward current. Ip was measured as K ϩ -activated outward current elicited by rapidly changing the extracellular solution from 0 mM K ϩ -to 5.4 mM K ϩ -modified Tyrode solution for 5 s. The holding potential was switched to Ϫ20 mV to obtain the maximal activation of Ip. Peak Ip was selected to evaluate Na ϩ -K ϩ -ATPase activity before and after 2-meSATP application, since the Na ϩ changes sensed by Na ϩ -K ϩ -ATPase are more accurately reflected by peak Ip than steady Ip (31) . The brief exposure to K ϩ containing extracellular solution minimized the change of the intracellular ion environment during 2-meSATP application. After peak Ip was obtained under control conditions, 3 M 2-meSATP was added to the superfusion solution for 3-4 min while the myocyte was clamped at Ϫ80 mV, and peak Ip was then measured again. Peak Ip after a 5-min washout was also obtained.
Cell shortening measurement. Cell shortening of ventricular myocytes was elicited by field stimulation at 0.5 Hz and was detected by a video edge detector device (Crescent Electronics, Sandy, UT) as previously described (28) .
Data and statistics. I NCX and Ip (in pA) were normalized to membrane capacitance (in pF). All data are shown as means Ϯ SE. Student's t-test for paired samples was used for statistical analysis unless otherwise indicated.
Mathematical simulation. Simulated I-V relationships for I NCX and Ip were based on previous formulations (14) . The equation for Ip was as follows: 
where V is voltage, F is Faraday's constant, R is the gas constant, and T is absolute temperature (in K). The factor can be further defined as follows:
and shows that the voltage dependence can be further modified by extracellular Na ϩ concentration ([Na ϩ ]o). In our case, Ip is set to 1.88 pA/pF based on the maximum calculated from our own Ip versus [Na ϩ ]i plot ( Fig. 1D ) instead of 1.5 pA/pF from the publication. All other parameter values were replicated from the original publication or given by experimental conditions: Km,Na i ϭ 10 mM, Km,
o ϭ 140 mM, and [Na ϩ ]i ϭ 10 mM for the basal condition and set at 11.2 mM to simulate effect of 2-meSATP treatment.
I NCX was defined by the following equation:
where kNCX is a scaling factor of INCX, Km,Na is the Na ϩ halfsaturation constant for INCX, Km,Ca is the Ca 2ϩ half-saturation constant for INCX, ksat is a saturation factor for INCX at very negative potentials, and is a factor controlling the voltage dependence of INCX. Km,Na is 87.5 mM, and Km,Ca is 1.38 mM. Keeping all appropriate concentration values and the original values for ksat and , an overall scaling factor (kNCX) was estimated to fit our INCX data using a least-squares fitting method in Excel.
Materials. KB-R7943 and 2-meSATP were obtained from SigmaAldrich (St. Louis, MO). YM-244769 was obtained from Tocris Bioscience (Bristol, UK).
RESULTS

Agonist activation of P2X4Rs increased peak I p . Na
ϩ -K ϩ -ATPase activity was measured in P2X4R TG ventricular myo-cytes using the protocol shown in Fig. 1A . Thus, 3 M 2-meSATP induced an inward current (1.4 Ϯ 0.36 pA/pF) in 11 of 17 TG myocytes (from 9 TG mice), confirming our previous results (27) . In these myocytes, the effect of the P2X agonist on I p was determined with a pipette Na ϩ concentration of 10 mM (Fig. 1B) . In response to 3 M 2-meSATP, peak I p increased to 0.58 Ϯ 0.03 pA/pF from a baseline value of 0.52 Ϯ 0.02 pA/pF (P Ͻ 0.05; Fig. 1C ), consistent with increased K ϩ -activated Na ϩ pump activity. We next estimated the increase in intracellular Na ϩ that could result from the P2X agonist-mediated increase in I p . To do this, stepwise increments of pipette Na ϩ concentration were made and increases in I p were determined (Fig. 1D ). The data describing the relationship between pipette Na ϩ concentration and I p were fitted by the following Hill equation:
is the Na ϩ concentration in the pipette and the Hill coefficient (h) was unrestrained and gave a value of 1.25. The K d value for Na ϩ concentration from the equation was 17.6 mM, similar to the value obtained by others (31) . Accordingly, back calculating from this equation, the 0.06 Ϯ 0.01 pA/pF net increase in peak I p would correspond to a 1.08 Ϯ 0.27 mM increase of intracellular Na ϩ during P2X agonist application.
P2X agonist enhances the Ca 2ϩ entry mode of I NCX . After the baseline Ni 2ϩ -sensitive current had been recorded, 3 M 2-meSATP was applied to myocytes held at Ϫ80 mV for 3-4 min. An inward current was observed in 10 of 15 TG myocytes (1.3 Ϯ 0.41 pA/pF from 8 TG mice; Fig. 2A ), indicating the presence of an inward P2X current. These 10 myocytes were further tested for an effect of the P2X agonist on I NCX by rapidly adding 10 mM NiCl 2 to calculate the Ni 2ϩ -sensitive current in the presence of 2-meSATP. The data shown in Fig.  2 , B and C, demonstrate that 2-meSATP caused an increase in Ni 2ϩ -sensitive current at positive potentials (0.55 Ϯ 0.09 pA/pF under control conditions vs. 0.82 Ϯ 0.14 pA/pF with 2-meSATP at 50 mV, P Ͻ 0.05). The P2X agonist had a minimal effect on I NCX at negative potentials (Ϫ0.46 Ϯ 0.06 pA/pF under control conditions vs. Ϫ0.45 Ϯ 0.05 pA/pF with 2-meSATP at Ϫ80 mV). These data indicate that 2-meSATP caused an increase of I NCX , notably at its Ca 2ϩ entry mode, helping extrude Na ϩ in exchange for Ca 2ϩ . From the I-V relationships of Ni 2ϩ -sensitive currents, the reversal potential of I NCX shifted from Ϫ14 Ϯ 2.3 mV under control conditions to Ϫ25 Ϯ 4.1 mV in response to 2-meSATP in these myocytes. We next calculated the change of intracellular Na ϩ that would cause such a shift of the I NCX reversal potential from the following equations:
where E Na-Ca is the I NCX reversal potential, E Na is the Na ϩ reversal potential, and E Ca is the Ca 2ϩ reversal potential, [Ca 2ϩ ] i is intracellular Ca 2ϩ concentration. In these calculations, the intracellular resting Ca 2ϩ was assumed to be 100 nM. With a negative shift of 11 Ϯ 3.52 mV in the reversal potential of I NCX after 2-meSATP, intracellular Na ϩ sensed by NCX would need to increase by 1.28 Ϯ 0.42 mM. If the resting Ca 2ϩ was 50 nM, the intracellular Na ϩ sensed by NCX would still increase by 1.0 Ϯ 0.34 mM. Subsarcolemmal [Ca 2ϩ ] i is difficult to estimate even if there is 10 mM EGTA in the pipette solution. This is due to the fact that EGTA is relatively ineffective in buffering Ca 2ϩ within 20 -100 nm of the pore (38) . Under the physiological condition of a living cardiac myocyte, 2-meSATP may cause an increase, even small, of the To verify that 2-meSATP increases the Ca 2ϩ entry mode of I NCX , Ni 2ϩ -sensitive current was measured at a holding potential of ϩ30 mV without running the ramp protocol before and after 3 M 2-meSATP application (Fig. 2D) . At 30 mV, Ni 2ϩ -sensitive current increased from 0.28 Ϯ 0.04 pA/pF under control conditions to 0.48 Ϯ 0.06 pA/pF (P Ͻ 0.05) after 2-meSATP (Fig. 2E) (Fig. 3A) . Similarly, the computationally derived I-V relationship of I NCX agreed well with our experimental results (Fig. 3B) . Thus, based on established mathematical models for the NCX and the Na ϩ pump (14) , the increase in [Na ϩ ] i and its corresponding stimulation of I NCX and I p agreed well with our experimental results.
We modified the scaling factor from 1.5 pA/pF in the original equation for the I p model (14) to our experimentally measured I p at 1.88 pA/pF. In the computerized model, I p is outwardly directed over the entire test potential range (Ϫ80 to ϩ50 mV) and is increased after a 1.2-mM increment of intracellular Na ϩ (Fig. 3A) . At Ϫ20 mV, the predicted increase in I p (0.04 pA/pF) was similar to the experimentally determined increase of 0.06 Ϯ 0.01 pA/pF after stimulation by 2-meSATP.
In the modeling of I NCX , the best fit for our experimental I NCX data caused us to use a k NCX value of 2,606.64 pA/pF instead of 2,000 pA/pF, as used by others (14) . The modeled I-V relationship of NCX shifted leftward upon the 1.2-mM step increase of intracellular Na ϩ from 10 to 11.2 mM. This leftward shift was not a parallel change since the primary effect was an increase in the Ca 2ϩ entry mode of I NCX with little if any change in the Ca 2ϩ exit mode. The computed shift of the I-V curve for I NCX was similar to the experimentally observed shift by 2-meSATP (Fig. 3B) -sensitive currents at ϩ30 mV before and after 2-meSATP application in a TG myocyte. E: plot of Ni 2ϩ -sensitive current at 30 mV under CTR conditions and during 2-me-SATP application. n ϭ 7 cells from 5 TG mice. P Ͻ 0.05. mentally (net increase of 0.27 Ϯ 0.10 pA/pF; Fig. 2C ). Overall, an elevated intracellular Na ϩ level has a more detectable effect on the Ca 2ϩ entry mode rather than the Ca 2ϩ exit mode of I NCX .
KB-R7943 or YM-244769 inhibits the 2-meSATP-induced increase of cell shortening. Extracellular 2-meSATP increases
cell shortening in TG cardiac myocytes (27) . To explore if the Ca 2ϩ entry mode of I NCX contributes to the increase of cell shortening by 2-meSATP in TG cardiac myocytes, KB-R7943 and a structurally different NCX inhibitor, YM-244769 (10), both of which preferentially oppose the Ca 2ϩ entry mode, were tested in TG myocytes. KB-R7943 at 5 M or YM-244769 at 0.1 M did not alter the basal cell shortening of TG myocytes (total of 19 myocytes from 7 TG mice; Fig. 4B ). Superfusion with 3 M 2-meSATP increased cell shortening by 29.2 Ϯ 3.7% above basal in 16 of 23 TG cardiac myocytes (from 10 TG mice) paced at 0.5 Hz (P Ͻ 0.05). When 5 M KB-R7943 was added in the continued presence of 2-meSATP, the increase of cell shortening was reduced to 13.8 Ϯ 3.9% above basal (P Ͻ 0.05; Fig. 4 , A and C). In another set of similar experiments, we tested the effect on 2-meSATP-stimulated cell shortening by YM-244769. In these experiments, 3 M 2-meSATP increased cell shortening by 31.4 Ϯ 7.1% in 10 of 15 TG cardiac myocytes (from 6 TG mice) paced at 0.5 Hz (P Ͻ 0.05). At 0.1 M, YM-244769 reduced 3 M 2-me-SATP-stimulated cell shortening to 17.3 Ϯ 7.4% above basal (P Ͻ 0.05; Fig. 4D ). Thus, either KB-R7943 or YM-244769 could inhibit the 2-meSATP-induced increase of cell shortening, indicating a role of the Ca 2ϩ entry mode in mediating the P2X agonist effect on myocyte contractility in these TG myocytes.
P2X agonist can stimulate I NCX in WT ventricular myocytes. To explore the physiological relevance of this receptor in modulating Na ϩ handling, the effects of a P2X agonist on I NCX Fig. 3 The actual experimental data under CTR conditions and after 2-meSATP application were also plotted for comparison with the simulation.
Fig. 4. KB-R7943 (KBR) or YM-244769 (YM) inhibits the 2-meSATP-induced increase of cell shortening (CS).
A: representative traces of CS in TG myocytes paced at 0.5 Hz for cells exposed to 2-meSATP and then to 2-meSATP plus KBR followed by WO. B: basal CS did not change after application of KBR (n ϭ 12) or YM (n ϭ 7). C: percent increases of CS above basal during application of 2-meSATP alone (percent above basal, n ϭ 16 cells from 10 Tg mice) and during the addition of KBR plus 2-meSATP (percent above basal with both KBR and 2-meSATP vs. that with 2-me-SATP alone, P Ͻ 0.05). D: percent increases of CS above basal during application of 2-meSATP alone (percent above basal, n ϭ 10 cells from 6 Tg mice) and during exposure of YM plus 2-meSATP (percent above basal with both YM and 2-meSATP vs. that with 2-meSATP alone, P Ͻ 0.05).
and myocyte contraction were tested in cardiac ventricular myocytes of WT mice. Application of 10 M 2-meSATP induced an inward current at Ϫ80 mV (0.68 Ϯ 0.26 pA/pF) in 8 of 34 WT ventricular myocytes (from 7 WT mice), similar to our previous findings (27) . These P2X agonist-responsive myocytes were then tested for changes in I NCX . 2-meSATP increased Ni 2ϩ -sensitive current at positive potentials (0.46 Ϯ 0.05 pA/pF at baseline vs. 0.59 Ϯ 0.06 pA/pF with 2-meSATP at ϩ50 mV, P Ͻ 0.05; Fig. 5A ). There were no significant changes by 2-meSATP in Ni 2ϩ -sensitive current at negative potentials (Ϫ0.40 Ϯ 0.09 pA/pF under control conditions vs. Ϫ0.42 Ϯ 0.09 pA/pF with agonist at Ϫ80 mV, P Ͼ 0.05). The primary effect on the Ca 2ϩ entry mode but not the Ca 2ϩ exit mode of NCX in WT myocytes was qualitatively the same as that found in myocytes from P2X4 TG hearts. The reversal potential of I NCX shifted from Ϫ13.25 Ϯ 1.72 to Ϫ17.5 Ϯ 1.29 mV in response to 2-meSATP (P Ͻ 0.05). These data demonstrate that a P2X agonist can also elicit an increase in the Ca 2ϩ entry mode of NCX in WT myocytes.
As further evidence for a physiological role of cardiac P2X4Rs, the effect of KB-R7943 on the P2X agonist-induced increase of cell shortening was tested in WT murine cardiac myocytes. In WT myocytes, the P2X agonist had little or no effect on basal contraction. To facilitate detection of an agonist-stimulated effect on cell shortening in WT myocytes, 3 M ivermectin, which selectively potentiates the P2X4 effect (17), was combined with 10 M 2-meSATP. The combined presence of 2-meSATP and ivermectin increased cell shortening by 14.8 Ϯ 3.1% above basal in 8 of 32 WT myocytes (from 7 WT mice) paced at 0.5 Hz (P Ͻ 0.05). The addition of 5 M KB-R7943 to 2-meSATP plus ivermectin reduced cell shortening to 7.2 Ϯ 2.3% above basal (P Ͻ 0.05; Fig. 5B ), similar to the response elicited by KB-R7943 in TG myocytes. The data support a link between the Ca 2ϩ entry mode of NCX and P2X4Rs in WT myocytes.
DISCUSSION
P2XRs are a family of ligand-gated ion channels (17, 36) . P2X4Rs are an important subtype of the endogenous P2XR channel in the cardiac myocyte. When activated by extracellular ATP, these channels conduct cations in a voltage-dependent manner with a reversal potential near 0 mV (17, 22) . As a Na ϩ entry pathway, these channels may have a physiological role in regulating cellular Na ϩ levels in cardiac myocytes. The objective here was to test the hypothesis that activation of these channels by extracellular ATP causes an increased cellular Na ϩ level in cardiac myocytes. We further determined whether the P2XR-induced stimulation of NCX has a role in modulating the contractile state of cardiac myocytes.
In the present study, we used myocytes from both TG and WT mice to test these concepts, which are supported by the following lines of evidence. First, the P2XR-mediated increase in Na ϩ entry into the myocyte (27) should stimulate I p because the pump functions to extrude intracellular Na ϩ . Indeed, activation of the P2X4R by its agonist, 2-meSATP, was able to increase I p in TG cardiac myocytes. Second, P2X agonist should stimulate I NCX , another cellular mechanism for Na ϩ extrusion. We found that in both WT and TG cardiac myocytes, 2-meSATP could stimulate the Ca 2ϩ entry mode of NCX. Third, an increase in cellular [Na ϩ ] i due to P2XR-mediated Na ϩ entry can be estimated in TG myocytes. For I p , which was only measured in TG myocytes, the magnitude of [Na ϩ ] i increase (1.08 Ϯ 0.27 mM) was calculated based on responses calibrated to concentration changes in pipette and, hence, cytosolic Na We attempted to measure directly [Na ϩ ] i in TG myocytes using the fluorescent Na ϩ indicator sodium benzofuran isophtalate. We could not detect any change in [Na ϩ ] i after 2-meSATP application in P2X4R TG myocytes (data not shown). This is not surprising given that the amount of the cellular Na ϩ increase is below the sensitivity of this Na ϩ -sensitive dye, the K d of which is 3.8 mM in the absence of K ϩ and 11.3 mM in the presence of physiological concentrations of K ϩ (Molecular Probes website). Swift et al. (32) observed that a low concentration of ouabain (0.3 M) increased contractility by 40% via its selective inhibition of the ␣ 2 -isoform of the Na ϩ pump, but they could not detect an increase in global [Na ϩ ] i by sodium benzofuran isophtalate in rat cardiac myocytes. They concluded that the increased contractility in response to 0.3 M ouabain could not be explained by a substantial global rise in [Na ϩ ] i . Similar to our finding of a P2X agonist-induced stimulation of NCX, a local accumulation of [Na ϩ ] i after ouabain was detectable by I NCX measurements (32) . It is thought that the Na ϩ concentration in the subsarcolemmal space is sensed by the Na ϩ pump, NCX, and other membrane transport mechanisms (3, 12, 13) . It is possible that the increase in I NCX or I p measured during cardiac P2X4 activation reflects an increase in subsarcolemmal Na ϩ concentrations. In studying the role of NCX in mediating the P2XR-induced effect on contraction, we used P2X4R-overexpressing TG cardiac myocytes. TG myocytes displayed a greater magnitude of P2XR-mediated increase in contraction and were a better model to determine the mechanism of the contractile effect of P2X agonist. We postulated that the Ca 2ϩ entry mode of NCX, stimulated by an intracellular Na ϩ elevation, contributes to the contraction increase by P2X agonist. This postulate is supported by our finding that the P2X agonist was able to enhance sarcoplasmic reticulum Ca 2ϩ content in P2X4R TG myocytes (29) . In the present study, KB-R7943 could inhibit the 2-meSATP-induced increase in cell shortening in TG myocytes. KB-R7943, at 5 M, can serve as a selective Ca 2ϩ entry mode inhibitor (23, 24) . Another structurally different selective inhibitor of the Ca 2ϩ entry mode (10), YM-244769, was also able to inhibit the 2-meSATP-induced stimulation of cell shortening in TG cells. Neither KB-R7943 nor YM-244769 affected basal cell shortening in these cardiac myocytes.
Several considerations deserve to be mentioned. Ca 2ϩ may enter directly through the P2X4R. Ca 2ϩ could contribute as much as 8% of the total inward current induced by ATP via the human homotrimeric P2X4R (4 Cardiac P2X4Rs may also be implicated under pathophysiological condition. mRNAs encoding all of the P2XRs have been demonstrated in the human left ventricle. P2XR protein expression was confirmed for all P2XRs except for P2X5 (1) . In left ventricular tissue from patients with congestive heart failure, the expression for P2X6 was upregulated compared with healthy control subjects (1) . Healthy tissues from the human right atrium and sinoatrial node also express P2X4, P2X5, P2X6, and P2X7 receptors, with P2X4Rs and P2X7 receptors being the most abundant (16) . Although these data do not localize the level of expression of P2X4Rs on endothelial cells, fibroblasts, or cardiac myocytes in the intact heart, it is likely that P2X4Rs on human cardiac myocytes have a role in regulating cardiac function under pathophysiological conditions such as heart failure or hypertrophy. Animal studies have lended further support to this concept. Calsequestrin-overexpressing cardiomyopathic hearts show an upregulation of P2X4Rs by immunoblot analysis and increased P2X current by 2-meSATP compared with WT hearts (26) . More recently, it has been shown that hypoxia could stimulate P2X4R upregulation in the right ventricle of rats (18) . Upregulated cardiac P2X4Rs during heart failure or hypoxia may exert a greater Na ϩ handling effect under such pathological conditions. Whether upregulation represents a compensatory salutary effect or causes the progression of heart disease remains to be determined. It is of interest that cardiac P2X4R overexpression has a salutary effect in heart failure and that knockout of endogenous cardiac myocyte P2X4Rs results in a more severe heart failure phenotype (37) . The mechanism of cardioprotection was shown to be activation of eNOS, presumably due to a localized microdomain Ca 2ϩ increase, which was, in turn, from the increased Ca 2ϩ entry mode of NCX and direct Ca 2ϩ conductance via the P2X4 channel. The data imply that any upregulation of P2X4Rs during heart failure is a compensatory protective mechanism.
In conclusion, the present study demonstrated a novel Na ϩ entry pathway through a sarcolemmal ligand-gated ion channel in adult murine ventricular myocytes of both receptor-overexpressing TG and WT mice. Both the experimental and simulated data on Na ϩ -K ϩ -ATPase and NCX highlighted a new Na ϩ entry pathway via the myocyte P2XR. Given the recent finding that cardiac P2X4Rs physically associate with eNOS (37), this purinergic Na ϩ entry pathway likely has important implications in the regulation of cardiac function.
